| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income before noncontrolling interests and temporary equity holders | 17,928 | -13,110 | 33,421 | 36,674 |
| Gains attributable to the fair value of future servicing rights, net of guaranty obligation | 46,773 | 50,060 | 48,657 | 80,964 |
| Change in the fair value of premiums and origination fees (note 2) | 13,412 | -11,352 | -7,311 | 16,798 |
| Amortization and depreciation | 62,964 | 62,084 | 60,041 | 116,557 |
| Stock compensation-equity and liability classified | NaN | 26,747 | NaN | NaN |
| Provision (benefit) for credit losses | 4,118 | 3,105 | 949 | 5,532 |
| Indemnified and repurchased loans expenses - loan repurchase losses | 6,950 | 20,092 | NaN | NaN |
| Deferred tax expense (benefit) | NaN | -5,829 | NaN | NaN |
| Fair value adjustments to contingent consideration liabilities | NaN | -8,243 | NaN | NaN |
| Impairment of real estate held for investment and equity method investment | NaN | 18,615 | NaN | NaN |
| Originations of loans held for sale | 3,906,787 | 5,922,141 | 5,946,275 | 5,310,528 |
| Proceeds from transfers of loans held for sale | 2,795,446 | 6,682,041 | 4,920,232 | 4,742,908 |
| Other operating activities, net | -64,346 | -4,182 | 24,859 | -12,941 |
| Receivables, net | NaN | 83,479 | NaN | NaN |
| Other assets | NaN | -29,203 | NaN | NaN |
| Other liabilities | NaN | 37,174 | NaN | NaN |
| Net cash provided by (used in) operating activities | -1,143,912 | 803,369 | -948,119 | -519,560 |
| Capital expenditures | 1,887 | 7,265 | 2,312 | 6,195 |
| Capital invested in equity-method investments | 3,118 | 8,628 | 1,127 | 16,792 |
| Purchases of pledged available-for-sale ('afs') securities | 22,894 | 15,000 | 10,000 | 21,989 |
| Proceeds from prepayment and sale of pledged afs securities | 3,341 | 14,923 | 7,153 | 4,547 |
| Originations and repurchase of loans held for investment | 23,418 | 236 | -236 | 24,381 |
| Other investing activities, net | -7,897 | -3,700 | -3,141 | -2,884 |
| Net cash provided by (used in) investing activities | -40,079 | -12,506 | -2,909 | -61,926 |
| Borrowings (repayments) of warehouse notes payable, net | 1,118,166 | -756,302 | 1,021,806 | 559,042 |
| Repayments of corporate notes payable | 1,125 | 1,125 | 1,125 | 329,606 |
| Borrowings of corporate notes payable | NaN | 0 | 0 | 398,875 |
| Repurchase of common stock | 19,100 | 183 | 1,038 | 9,232 |
| Cash dividends paid | 23,605 | 22,974 | 22,970 | 45,858 |
| Payment of contingent consideration | 60 | 1,393 | 0 | 10,954 |
| Debt issuance costs | 343 | 350 | 697 | 14,964 |
| Other financing activities, net | 112 | -2,027 | 150 | -947 |
| Net cash provided by (used in) financing activities | 1,074,045 | -784,354 | 996,126 | 546,356 |
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents (note 2) | -109,946 | 6,509 | 45,098 | -35,130 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | 344,375 | 337,866 | 327,898 | NaN |
| Total of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period | 234,429 | 344,375 | 337,866 | NaN |
Walker & Dunlop, Inc. (WD)
Walker & Dunlop, Inc. (WD)